Business Segments Summit Therapeutics Inc.
Equities
SMMT
US86627T1088
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.27 USD | -2.15% |
|
-8.28% | -1.26% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Drug Development | 860K | 1.81M | 705K | - | - | |||||
Total Assets | 102M | 113M | 664M | 203M | 436M | |||||
Interest Expense | -255K | -281K | -4.4M | -16.46M | -8.69M | |||||
Income Tax Expense | -213K | - | - | - | - | |||||
CAPEX | -421K | -306K | -624K | -128K | -139K | |||||
EBT | -52.91M | -88.6M | -78.78M | -615M | -221M | |||||
D&A | 2M | 2.46M | 2.51M | 2.05M | 89K | |||||
Operating Income | -53.19M | -86.19M | -72.09M | -610M | -226M | |||||
Net Income | -52.7M | -88.6M | -78.78M | -615M | -221M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) |
|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 102M | 2.76M | 2.52M | 808K | - | |||||
Latin America | 860K | 1.81M | 705K | - | - | |||||
United States | - | - | - | - | - | |||||
Total Assets | - | 722K | 2.56M | 5.25M | 436M | |||||
Europe | - | - | - | - | - |
- Stock Market
- Equities
- SMMT Stock
- Financials Summit Therapeutics Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition